ambIT* PIB IL v 1.5 220571Recalls & reported problems
Avanos Medical, Inc. · PIB IL v 1.5 · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00193494001384), received between May 17, 2023 and May 17, 2023 — classified as 1 malfunction.
The most frequently reported specific device problem is “Excess Flow or Over-Infusion” (1 report).
5 other recalls cover devices cleared under the same FDA submission (K162165); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Excess Flow or Over-Infusion1
Patient problems
- No Clinical Signs, Symptoms or Conditions1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
MalfunctionMay 17, 2023Excess Flow or Over-Infusion; Excess Flow or Over-Infusion
FILL VOLUME: 500 ML. FLOW RATE: 8ML/HR, BOLUS 6ML EVERY 20 MIN. PROCEDURE: ANTERIOR CRUCIATE LIGAMENT/MEDIAL COLLATERAL LIGAMENT (ACL/MCL) REPAIR. CATHPLACE: UNKNOWN. INFUSION START TIME: (B)(6) 2023. INFUSION STOP TIME: (B)(6) 2023. IT WAS REPORTED, THE AMBIT PUMP ¿SEEMED TO RUN OUT OF MEDS EARLY FRIDAY MORNING¿... ¿AMBIT RAN OUT AT 5AM ON 24TH-HAD ONLY PUSHED BUTTON 2X FOR EXTRA MEDS¿. DURING A PHONE CALL THE PATIENT STATED, ¿THE PUMP INFUSED TOO QUICKLY BUT I AM NOT REALLY SURE...I GUESS THAT WAS HOW THE DOCTOR PROGRAMMED THE PUMP....I JUST EXPECTED THE PUMP TO LAST LONGER¿. SHE REPORTED, SHE BELIEVED THE PUMP WAS STARTED AROUND 5PM THE DAY OF HER SURGERY ON (B)(6) 2023. THE PATIENT DENIED EXPERIENCING ANY ADVERSE SIDE EFFECTS: NO DIZZINESS, RINGING OF EARS, BLURRED VISION, METALLIC TASTE IN MOUTH, ETC. THERE WAS NO REPORTED INJURY.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 16949903 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K162165. One submission often covers many models, so check the product and lot details in each record.
- Z-1688-2023 · Apr 24, 2023 · TerminatedambIT Cassette Filter Male Luer, Product Code: 220266
- Z-1685-2023 · Apr 24, 2023 · TerminatedAVNS ambIT System - PIB/PCA W 5in Cath, Product Code: 220507
- Z-1686-2023 · Apr 24, 2023 · TerminatedSMMT ambIT Kit Basic Filter Luer Cass, Product Code: 220537
- Z-1684-2023 · Apr 24, 2023 · TerminatedAVNS ambIT System - PIB/PCA W 2.5in Cath, Product Code: 220509
- Z-1687-2023 · Apr 24, 2023 · TerminatedSMMT ambIT Reusable Program - Luer Cass, Product Code: 220568
Other Pump, infusion, pca devices
- Alaris 8120Carefusion 303, Inc. · Pump, infusion, pca2 recalls4 deaths14,640 reports
- CADD 21-2111-0402-51Icu Medical, Inc. · Pump, infusion, pca4 recalls1,535 reports
- CADD 21-2111-0300-01Icu Medical, Inc. · Pump, infusion, pca1 recall1,116 reports
- Alaris™ PCA Module, Model 8120Carefusion 303, Inc. · Pump, infusion, pca2 recalls1 death917 reports
- Nimbus II PlusInfutronix LLC · Pump, Infusion, Pca1 recall1 death800 reports
- CADD 21-2112-0300-01Icu Medical, Inc. · Pump, infusion, pca1 recall406 reports
- CADD 21-6300-51Icu Medical, Inc. · Pump, infusion, pca414 reports
- Nimbus II PainPROInfutronix LLC · Pump, Infusion, Pca2 recalls186 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page